abstract |
Inhibitors of BET bromodomains and compositions containing the same are disclosed. Also disclosed are methods of using BET Bromodomain inhibitors in the treatment of diseases and conditions for which inhibition of BET Bromodomain proteins is beneficial, such as cancer. |